SlideShare a Scribd company logo
1 of 13
Download to read offline
1	
Tyrosinase Enzyme Kinetics Attached to L-Dopa and Inhibition Using
Sodium Benzoate
Alison O’Malley
Metropolitan State University of Denver
December 12, 2013
CHE: 4450
Lab Partners: Nellie Kaufman and Brett White
2	
Abstract
Tyrosinase enzymatic activity was studied from the mushroom Agaricus
bisporous to find the kinetic constants Km and Vmax using L-dopa as the substrate. The
inhibitor sodium benzoate at concentrations 0.1 mM and 0.2 mM was used to study the
effects of inhibition on Tyrosinase. The values of the Km and Vmax reflected mixed
inhibition as the numerical values both changed upon the addition of sodium benzoate.
With the kinetic constant values and the Line-Weaver Burke graph, it was determined
that sodium benzoate was a mixed inhibitor with an emphasis on uncompetitive
inhibition. Experimental conditions such as human errors in pipetting, moisture in the air,
cleanliness of equipment, and age of tyrosinase preparation influenced the data.
Introduction
Enzymes are biological macromolecule catalysts that play a very crucial part in
the body, speeding up chemical reactions that would otherwise take a very long time to
occur. They are characterized by two fundamental properties. First they increase the
rate of chemical reactions without themselves being consumed or permanently altered
by the reaction. Second, they increase reaction rates without altering the chemical
equilibrium between reactants and products (4). Enzymes accomplish this by altering
the substrates binding site to resemble the transition state. They bind to a substrate
through two most common configurations. The primary configuration is through induced
fit in which the confirmation of the enzyme and substrate are altered so it resembles the
transition state. The second way is through the lock and key mechanism in which the
3	
substrate fits perfectly into the active site of the enzyme. In cases where multiple
enzymes are involved in the catalysis, specific amino acid side chains in the active site
may react with the substrate and form bonds with reaction intermediates (1).
Tyrosinase is a multifunctional, glycosylated, and copper-containing oxidase,
which catalyzes the first two steps in mammalian melanogenesis (3). Inhibitors are
molecules that bind to enzymes and decrease their activity. Two types of inhibitors exist
with different results. One type is the inhibitors that are irreversible which initiate
permanent damage to the enzyme. The other types are reversible and encompass four
major categories: competitive, uncompetitive, non-competitive, and mixed competitive
inhibition (5). The first purpose of this study was to determine the kinetic constants Km
and Vmax using L-dopa as the substrate. The second portion was to examine the
effects of a chosen inhibitor, sodium benzoate on the enzymatic activity of Tyrosinase
and to determine the type of inhibition interaction of substrate and enzyme.
Materials and Methods
Enzyme kinetics of tyrosinase: The first step to this was to determine the optimal
enzyme concentration of tyrosinase. This was done by varying the tyrosinase solution
(preparation “A” ~100 units/ml), while keeping the 5 mM L-Dopa concentration constant.
The total amount of material was always the same with the addition of 0.1 potassium
phosphate buffer (pH 7.0) to bring the solution to 1.10 ml. The tyrosinase was stored on
ice during the entire experiment. The spectrophotometer (Vernier™ probes) was set to
470 nm. The phosphate buffer was used to calibrate the spectrophotometer. The
4	
phosphate buffer and L-dopa were pipetted directly into tubes according to the table 1.
The tubes were then vortexed. The following steps were rapidly performed: 10 ml of
enzyme solution from the first tube was poured into the first test tube, then poured into
the 1-cm cuvette, and the cuvette was put into the spectrophotometer. Timing was
immediately started and absorbance vs. time data was recorded every 2 minutes. Initial
rate was determined from the graph on the computer. The second part of this
experiment was to determine the Km and Vmax for L-dopa. In this part the enzyme
concentration was held constant whilst the amount of L-dopa was varied from
unsaturated-saturated. A table was set up similar to table 1. which also included 6
assays with 75 ul enzyme concentration and varying amounts of L-dopa from 0.15 to
5.0 mM, those amounts were 25, 50, 75, 100, 25 , and 1000 µl L-dopa. The remaining
volume was phosphate buffer to make a final volume of 1.10 ml. The buffer and L-dopa
was pipetted into a test tube and vortexed. This was repeated on all 6 test tubes and 6
enzyme assays were collected successively. The absorbances were collected at 2 min
and the ΔA/min for each level of L-dopa was charted.
Inhibition of tyrosinase: The previous experiment was performed twice with a 5 .0
mM sodium benzoate inhibitor added to each assay. The sodium benzoate was used in
two different concentrations for each trial, 0.1 M and 0.2 M. The inhibitor amount was
always the same during each trial. The optimal amount of enzyme determined in the
previous was determined by varying the 5.0 mM L-Dopa amount. The other variable
were held constant. The total amount of solution was also 1.10 ml with the addition of
the potassium phosphate buffer solution. Six different amounts of L-Dopa were
prepared as in table 3 & 4. This part of the experiment was performed the same way as
5	
previously done. For each assay, the absorbance vs. time was recorded every 2
minutes. The data was converted to a Hanes-Wolf plot for each assay. The kinetic
constants were determined from this plot. The data was then used to create a double
reciprocal Lineweaver-Burk plot. The inhibition type of sodium benzoate was
determined from this plot.
Results
Table 1: General Protocol for Tyrosinase Assay
Material (µl) 1 2 3 4 5
Phosphate
Buffer
90 80 50 25 0
L-Dopa 1000 1000 1000 1000 0
Tyrosinase 10 20 50 75 100
Table 2: Protocol for Tyrosinase Assay with enzyme concentration held constant
and amount of L-Dopa varied over a range from non-saturation to saturation
Material
(µl)
1 2 3 4 5 6
Buffer 1000 975 950 925 775 250
L-Dopa 25 50 75 100 250 1000
Tyrosinase 75 75 75 75 75 75
Substrate
conc. [S]
(µM)
114 227 341 455 1140 4550
Table 3: 0.1 M Sodium Benzoate in a 5 mM solution in 0.1 M phosphate buffer pH
7.0
Material
(µl)
1 2 3 4 5 6
Buffer 980 950 930 905 755 5
L-Dopa 25 50 75 100 250 1000
Tyrosinase 75 75 75 75 75 75
Inhibitor 22 22 22 22 22 22
6	
Table 4: 0.2M Sodium Benzoate in a 5 mM solution in 0.1 M phosphate buffer pH
7.0
Material
(µl)
1 2 3 4 5 6
Buffer 956 931 906 881 731 0
L-Dopa 25 50 75 100 250 1000
Tyrosinase 75 75 75 75 75 75
Inhibitor 44 44 44 44 44 44
Table 5: Kinetic constant values for Tyrosinase uninhibited and inhibited
Kinetic Constant
Tyrosinase
Uninhibited 0.1mM sodium
benzoate
0.2 mM sodium
benzoate
Km (µM) 490.35 293.25 259
Vmax (µM)/s 500 250 250
Figure 1: Spectral data of tyrosinase assay that was used to determine the optimal
enzyme concentration
R²	=	0.9996	
R²	=	0.99946	
0	
0.05	
0.1	
0.15	
0.2	
0.25	
0.3	
0.35	
0.4	
0.45	
0.5	
0	 20	 40	 60	 80	 100	 120	
Absorbance		
Time	(s)	
Spectral	Data	of	Tyrosinase	Assay	
Assay	1	
Assay	2	
Assay	3	
Assay	4	
Assay	5	
Linear	(Assay	3)	
Linear	(Assay	4)
7	
Figure 2: Spectral data, which was used to determine the Km and Vmax of uninhibited
tyrosinase assays
y	=	2E+06x	+	980.7	
R²	=	0.99041	
0	
1000	
2000	
3000	
4000	
5000	
6000	
7000	
8000	
9000	
10000	
0	 0.0005	 0.001	 0.0015	 0.002	 0.0025	 0.003	 0.0035	 0.004	 0.0045	 0.005	
[S]/v	(sec)	
[S]	(M)	
Hanes-Woolf	Plot	
y	=	4E+06x	+	1037	
R²	=	0.99469	
0	
2000	
4000	
6000	
8000	
10000	
12000	
14000	
16000	
18000	
20000	
0	 0.0005	 0.001	 0.0015	 0.002	 0.0025	 0.003	 0.0035	 0.004	 0.0045	 0.005	
[S}/v	(sec)	
[S]	(M)	
Hanes-Woolf	Plot
8	
Figure 3: Spectral data, which was used to determine the Km and Vmax of inhibited
Tyrosinase assays with 0.1 mM sodium benzoate inhibitor
Figure 4: Spectral data, which was used to determine the Km and Vmax of inhibited
tyrosinase assays with 0.2 mM sodium benzoate inhibitor
y	=	4E+06x	+	1037	
R²	=	0.99469	
0	
2000	
4000	
6000	
8000	
10000	
12000	
14000	
16000	
18000	
20000	
0	 0.0005	 0.001	 0.0015	 0.002	 0.0025	 0.003	 0.0035	 0.004	 0.0045	 0.005	
[S}/v	(sec)	
[S]	(M)	
Hanes-Woolf	Plot
9	
Figure 5: Double reciprocal plot of uninhibited Tyrosinase and inhibited Tyrosinase by
sodium benzoate
The optimal enzyme concentration was determined to be 6.8 units/ml of
Tyrosinase based off fig. 1. From this figure the optimal amount of enzyme was
determined to be that used in assay 4 (table 1): 75 µl of ~100 units/ml were added to
each ~1.10 ml assay. Table 2-4 show the amounts of each substance used for
uninhibited tyrosinase and the two trials of inhibited tyrosinase by sodium benzoate. By
using the data showed in fig. 2 the kinetic constants Km and Vmax for uninhibited
tyrosinase were determined to be 490.35 µM and 500 µM/s. Figs.3 & 4 depicts the two
reactions with the different concentrations of inhibitor. The significance of fig.5 is that it
-6000000	
-4000000	
-2000000	
0	
2000000	
4000000	
6000000	
8000000	
10000000	
12000000	
14000000	
-10000	 -8000	 -6000	 -4000	 -2000	 0	 2000	 4000	 6000	 8000	 10000	
1/[v]	(2/M)	
1/[S](/M)	
Lineweaver-Burke	Plot	
0.1mM	
uninhibited	
0.2mM	
Linear	(uninhibited)	
Linear	(0.2mM)
10	
illustrates the type of inhibitor sodium benzoate. Table 5 shows the determined kinetic
constants from each of three trials.
Discussion
In the first part of the experiment the optimal concentration of tyrosianse was
determined using uninhibited tyrsoinase assay of varying concentrations while keeping
L-Dopa constant. The data from spectrophotometer fig. 1 reveals that both assays 3
and 4 from table 2 delivered the most useful concentrations because the slopes were
steep and very linear. Of the two, assay 4 was chosen because it had a larger
concentration and subsequently gave a stronger spectrophotometer signal than assay
3.
With the combination of the previous data and the L-Dopa concentrations from
table 2 the kinetic constants for uninhibited tyrosinase were determined (Km= 400.35
µM; Vmax=500 µM/s). The literature values for uninhibited tyrosinase from the
mushroom Agaricus bisporous were: Km= 170 µM-1500 µM (6)(7) and Vmax 24.5 ± 1.0
mM/min - 60 mM/min ≈ 1470(± 60) - 3600 mM/s (6)(7)(8). The Vmax as a result of this
experiment did not fall within the literature range. However, the literature values varied
greatly and therefore the values obtained in this experiment were likely valid results.
Due to the fact these wide ranges exist it is evident that this experiment depends less
on enzyme and substrate and more on experimental conditions. These experimental
conditions include human error in pipetting, moisture in the lab as well as lab
temperature, and age of the tyrosinase preparation
11	
The data from the Lineweaver Burke plot fig.5 contradicts the numerical data of the
kinetic constants table 5. At first the plot from fig.5 looks like it is reflecting mixed or non-
competitive inhibition. However, upon evaluation of the numerical changes of the kinetic
constants from table 5 (Vmax and Km change) in relation to the plot, the complete
assessment indicated mixed inhibition. The plot from fig. 5 does not indicate classic
uncompetitive inhibition, which would necessitate the uninhibited line and both the
inhibited lines be parallel. However, only the line representing the 0.2 mM concentration
of sodium benzoate and the uninhibited line demonstrate uncompetitive inhibition. In
conclusion, the inhibition of tyrosinase by sodium benzoate is most likely mixed with a
probable emphasis on uncompetitive. The experimental conditions strongly influenced
the outcome of the Km and Vmax. This pertinent information could direct future
experiments to produce more accurate results.
12	
References
1) Sheng-Chang,T. (2009). An updated review of Tyrosinase inhibitors. International
Journal of Molecular Science, 10(6), 2440-2475 DOI:
http://dx.doi.org/10.3390%2Fijms10062440
2) Xie, J., Song, K.,Qiu, He,L., Q.,Huang,H., Chen, Q. (2007). Inhibitory effects of
substrate analogues on enzyme activity and substrate specificities of mushroom
tyrosinase. Food Chemistry, 103(4), 1075-1079 DOI:10.1016/j.foodchem.2006.04.030
3) Chung, K., Jeong, H., Jang, E., Choi, Y., Kim, D., Kim, S., Lee, K., Lee, H.,Chun, P.,
Byun, Y., Moon,H., Chung, H.(Oct2013). Characterization of a small molecular inhibitor
of melanogenesis that inhibits tyrosinase activity and scavenges nitric oxide. BBA-
General Studies. DOI: 1830(10), 4752-4761.
4) Cooper, G. (2000). The cell: A molecular approach. 2nd
edition. Sinauer Associates.
Retrieved on December 6, 2013, from http://www.ncbi.nlm.nih.gov/books/NBK9921/
5) Cornish-Browden, A. (1974). A simple graphical method for determining the
inhibition constants of mixed, uncompetitive, and non-competitive inhibitors. Biochem J,
137(1) 143-144. Rertreieved on December 9, 2013, from http://0-
www.ncbi.nlm.nih.gov.skyline.ucdenver.edu/pmc/articles/PMC1166095/
6) Sigma-Adlrich (2011). Tyrosinase from mushroom - lyophilized powder, ≥1000
unit/mg solid [Product Specification].
http://www.sigmaaldrich.com/Graphics/COfAInfo/SigmaSAPQM/SPEC/T3/T3824/T3824
BULK_SIGMA_.pdf
13	
7) Selinheimo, E., Gasparetti, C., Mattinen, M., et al. (2009) Enzyme Microb.
Technol. 44,1-10.
8) Espin, J. C., Varon, R., Fenoll, L. G., et al. (2000) Kinetic characterization of the
substrate specificity and mechanism of mushroom tyrosinase. European J. Biochem.,
267: 1270–1279.

More Related Content

What's hot

Enzyme assay methods
Enzyme assay methodsEnzyme assay methods
Enzyme assay methodsAthira RG
 
Enzyme Kinetics of Polyphenol oxidase
Enzyme Kinetics of Polyphenol oxidaseEnzyme Kinetics of Polyphenol oxidase
Enzyme Kinetics of Polyphenol oxidasenathan cash
 
ASBMB MT Poster-2014-Final
ASBMB MT Poster-2014-FinalASBMB MT Poster-2014-Final
ASBMB MT Poster-2014-FinalPhuc Nguyen
 
Extractive Spectrophotometric Determination of Ulipristal Acetate using Napht...
Extractive Spectrophotometric Determination of Ulipristal Acetate using Napht...Extractive Spectrophotometric Determination of Ulipristal Acetate using Napht...
Extractive Spectrophotometric Determination of Ulipristal Acetate using Napht...Ratnakaram Venkata Nadh
 
Advanced Biochemistry Lab
Advanced Biochemistry Lab Advanced Biochemistry Lab
Advanced Biochemistry Lab Hannah Barber
 
Measurement of Tyrosinase Activity using LAMBDA UV/Vis Spectrophotometer
Measurement of Tyrosinase Activity using LAMBDA UV/Vis SpectrophotometerMeasurement of Tyrosinase Activity using LAMBDA UV/Vis Spectrophotometer
Measurement of Tyrosinase Activity using LAMBDA UV/Vis SpectrophotometerPerkinElmer, Inc.
 
Nutrition Reseach - Enhanced brown adipose tissue differentiation in PTP1B kn...
Nutrition Reseach - Enhanced brown adipose tissue differentiation in PTP1B kn...Nutrition Reseach - Enhanced brown adipose tissue differentiation in PTP1B kn...
Nutrition Reseach - Enhanced brown adipose tissue differentiation in PTP1B kn...Aroldo Trejo
 
Preparation and evaluation of electrospun nanofibers containing pectin and ti...
Preparation and evaluation of electrospun nanofibers containing pectin and ti...Preparation and evaluation of electrospun nanofibers containing pectin and ti...
Preparation and evaluation of electrospun nanofibers containing pectin and ti...Nanomedicine Journal (NMJ)
 
In-vitro antioxidant and GC-MS analysis ethanolic extract of poly herbal drug
In-vitro antioxidant and GC-MS analysis ethanolic extract of poly herbal drugIn-vitro antioxidant and GC-MS analysis ethanolic extract of poly herbal drug
In-vitro antioxidant and GC-MS analysis ethanolic extract of poly herbal drugSkyfox Publishing Group
 
Expression and Purification of His-tag β-galactosidase Enzyme from E.coli
 Expression and Purification of His-tag β-galactosidase Enzyme from E.coli Expression and Purification of His-tag β-galactosidase Enzyme from E.coli
Expression and Purification of His-tag β-galactosidase Enzyme from E.coliSurayya Sana
 
Evaluation of antioxidant potential of Drugs
Evaluation of antioxidant potential of DrugsEvaluation of antioxidant potential of Drugs
Evaluation of antioxidant potential of DrugsRudresh Rudri
 
Enzyme kinetics of β-gal
Enzyme kinetics of β-galEnzyme kinetics of β-gal
Enzyme kinetics of β-galSurayya Sana
 
Antibacterial acivity of tetrahydropentagamavunon 0 (thpgv-0) and tetrahydrop...
Antibacterial acivity of tetrahydropentagamavunon 0 (thpgv-0) and tetrahydrop...Antibacterial acivity of tetrahydropentagamavunon 0 (thpgv-0) and tetrahydrop...
Antibacterial acivity of tetrahydropentagamavunon 0 (thpgv-0) and tetrahydrop...Alexander Decker
 
Protein separation using magnetic nanoparticles
Protein separation using magnetic nanoparticlesProtein separation using magnetic nanoparticles
Protein separation using magnetic nanoparticlesAntonio Maldonado
 
Isolation and characterization of polyphenol oxidase from phyllanthus emblica...
Isolation and characterization of polyphenol oxidase from phyllanthus emblica...Isolation and characterization of polyphenol oxidase from phyllanthus emblica...
Isolation and characterization of polyphenol oxidase from phyllanthus emblica...IJSIT Editor
 
BarreraBasnetDelgadoLamichhaneShifatuShrestha_Report2_4140_S13
BarreraBasnetDelgadoLamichhaneShifatuShrestha_Report2_4140_S13BarreraBasnetDelgadoLamichhaneShifatuShrestha_Report2_4140_S13
BarreraBasnetDelgadoLamichhaneShifatuShrestha_Report2_4140_S13Juan Barrera
 
Discovery Day 2014 Final Poster - JP
Discovery Day 2014 Final Poster - JPDiscovery Day 2014 Final Poster - JP
Discovery Day 2014 Final Poster - JPJustin Pezick
 

What's hot (20)

Enzyme assay methods
Enzyme assay methodsEnzyme assay methods
Enzyme assay methods
 
Enzyme Kinetics of Polyphenol oxidase
Enzyme Kinetics of Polyphenol oxidaseEnzyme Kinetics of Polyphenol oxidase
Enzyme Kinetics of Polyphenol oxidase
 
ASBMB MT Poster-2014-Final
ASBMB MT Poster-2014-FinalASBMB MT Poster-2014-Final
ASBMB MT Poster-2014-Final
 
Extractive Spectrophotometric Determination of Ulipristal Acetate using Napht...
Extractive Spectrophotometric Determination of Ulipristal Acetate using Napht...Extractive Spectrophotometric Determination of Ulipristal Acetate using Napht...
Extractive Spectrophotometric Determination of Ulipristal Acetate using Napht...
 
Advanced Biochemistry Lab
Advanced Biochemistry Lab Advanced Biochemistry Lab
Advanced Biochemistry Lab
 
Measurement of Tyrosinase Activity using LAMBDA UV/Vis Spectrophotometer
Measurement of Tyrosinase Activity using LAMBDA UV/Vis SpectrophotometerMeasurement of Tyrosinase Activity using LAMBDA UV/Vis Spectrophotometer
Measurement of Tyrosinase Activity using LAMBDA UV/Vis Spectrophotometer
 
Nutrition Reseach - Enhanced brown adipose tissue differentiation in PTP1B kn...
Nutrition Reseach - Enhanced brown adipose tissue differentiation in PTP1B kn...Nutrition Reseach - Enhanced brown adipose tissue differentiation in PTP1B kn...
Nutrition Reseach - Enhanced brown adipose tissue differentiation in PTP1B kn...
 
Final Report
Final ReportFinal Report
Final Report
 
Preparation and evaluation of electrospun nanofibers containing pectin and ti...
Preparation and evaluation of electrospun nanofibers containing pectin and ti...Preparation and evaluation of electrospun nanofibers containing pectin and ti...
Preparation and evaluation of electrospun nanofibers containing pectin and ti...
 
In-vitro antioxidant and GC-MS analysis ethanolic extract of poly herbal drug
In-vitro antioxidant and GC-MS analysis ethanolic extract of poly herbal drugIn-vitro antioxidant and GC-MS analysis ethanolic extract of poly herbal drug
In-vitro antioxidant and GC-MS analysis ethanolic extract of poly herbal drug
 
Expression and Purification of His-tag β-galactosidase Enzyme from E.coli
 Expression and Purification of His-tag β-galactosidase Enzyme from E.coli Expression and Purification of His-tag β-galactosidase Enzyme from E.coli
Expression and Purification of His-tag β-galactosidase Enzyme from E.coli
 
Evaluation of antioxidant potential of Drugs
Evaluation of antioxidant potential of DrugsEvaluation of antioxidant potential of Drugs
Evaluation of antioxidant potential of Drugs
 
Artigo bioterra v16_n2_10
Artigo bioterra v16_n2_10Artigo bioterra v16_n2_10
Artigo bioterra v16_n2_10
 
Enzyme kinetics of β-gal
Enzyme kinetics of β-galEnzyme kinetics of β-gal
Enzyme kinetics of β-gal
 
Opioides en la comida
Opioides en la comidaOpioides en la comida
Opioides en la comida
 
Antibacterial acivity of tetrahydropentagamavunon 0 (thpgv-0) and tetrahydrop...
Antibacterial acivity of tetrahydropentagamavunon 0 (thpgv-0) and tetrahydrop...Antibacterial acivity of tetrahydropentagamavunon 0 (thpgv-0) and tetrahydrop...
Antibacterial acivity of tetrahydropentagamavunon 0 (thpgv-0) and tetrahydrop...
 
Protein separation using magnetic nanoparticles
Protein separation using magnetic nanoparticlesProtein separation using magnetic nanoparticles
Protein separation using magnetic nanoparticles
 
Isolation and characterization of polyphenol oxidase from phyllanthus emblica...
Isolation and characterization of polyphenol oxidase from phyllanthus emblica...Isolation and characterization of polyphenol oxidase from phyllanthus emblica...
Isolation and characterization of polyphenol oxidase from phyllanthus emblica...
 
BarreraBasnetDelgadoLamichhaneShifatuShrestha_Report2_4140_S13
BarreraBasnetDelgadoLamichhaneShifatuShrestha_Report2_4140_S13BarreraBasnetDelgadoLamichhaneShifatuShrestha_Report2_4140_S13
BarreraBasnetDelgadoLamichhaneShifatuShrestha_Report2_4140_S13
 
Discovery Day 2014 Final Poster - JP
Discovery Day 2014 Final Poster - JPDiscovery Day 2014 Final Poster - JP
Discovery Day 2014 Final Poster - JP
 

Viewers also liked

Viewers also liked (8)

Enzyme Lab
Enzyme LabEnzyme Lab
Enzyme Lab
 
Pure White 2008 Cdr
Pure White 2008 CdrPure White 2008 Cdr
Pure White 2008 Cdr
 
The Science of Melanin
The Science of MelaninThe Science of Melanin
The Science of Melanin
 
Copper in proteins and enzymes
Copper in proteins and enzymesCopper in proteins and enzymes
Copper in proteins and enzymes
 
Melanin synthesis
Melanin synthesisMelanin synthesis
Melanin synthesis
 
Biology of Melanocyte
Biology of MelanocyteBiology of Melanocyte
Biology of Melanocyte
 
Disorders of Hyperpigmentation
Disorders of HyperpigmentationDisorders of Hyperpigmentation
Disorders of Hyperpigmentation
 
Dendritic cells
Dendritic cellsDendritic cells
Dendritic cells
 

Similar to Enzyme Kinetics-2013

Siavosh Naji-Talakar[email protected]TITLE Enzyme Kineti.docx
Siavosh Naji-Talakar[email protected]TITLE Enzyme Kineti.docxSiavosh Naji-Talakar[email protected]TITLE Enzyme Kineti.docx
Siavosh Naji-Talakar[email protected]TITLE Enzyme Kineti.docxedgar6wallace88877
 
Toxic Interaction Mechanism of food Colorant Sunset Yellow with trypsin by Sp...
Toxic Interaction Mechanism of food Colorant Sunset Yellow with trypsin by Sp...Toxic Interaction Mechanism of food Colorant Sunset Yellow with trypsin by Sp...
Toxic Interaction Mechanism of food Colorant Sunset Yellow with trypsin by Sp...AI Publications
 
76 Lab Review
76 Lab Review76 Lab Review
76 Lab Reviewflguppie
 
Lab review
Lab reviewLab review
Lab reviewktanaka2
 
Lab review
Lab reviewLab review
Lab reviewktanaka2
 
A Simple and Validated RP-HPLC Method for the Estimation of Methylcobalamin i...
A Simple and Validated RP-HPLC Method for the Estimation of Methylcobalamin i...A Simple and Validated RP-HPLC Method for the Estimation of Methylcobalamin i...
A Simple and Validated RP-HPLC Method for the Estimation of Methylcobalamin i...Alok Singh
 
Microchimica Acta Volume 75 issue 3-4 1981 [doi 10.1007_bf01196393] G. A. Mil...
Microchimica Acta Volume 75 issue 3-4 1981 [doi 10.1007_bf01196393] G. A. Mil...Microchimica Acta Volume 75 issue 3-4 1981 [doi 10.1007_bf01196393] G. A. Mil...
Microchimica Acta Volume 75 issue 3-4 1981 [doi 10.1007_bf01196393] G. A. Mil...Sekheta Bros Company
 
Determination of metronidazole from the solid dosage form
Determination of metronidazole from the solid dosage formDetermination of metronidazole from the solid dosage form
Determination of metronidazole from the solid dosage formAtai Rabby
 
Blood amps poster_090210
Blood amps poster_090210Blood amps poster_090210
Blood amps poster_090210Jervin22000
 
FORMULATION AND EVALUATION OF ATORVASTATIN CALCIUM NIOSOMES.pptx
FORMULATION AND EVALUATION OF ATORVASTATIN CALCIUM NIOSOMES.pptxFORMULATION AND EVALUATION OF ATORVASTATIN CALCIUM NIOSOMES.pptx
FORMULATION AND EVALUATION OF ATORVASTATIN CALCIUM NIOSOMES.pptxshivalisingla5
 
Sensitive Analyses of Opiates and Opioids in Whole Blood Using Tip-on-Tip wit...
Sensitive Analyses of Opiates and Opioids in Whole Blood Using Tip-on-Tip wit...Sensitive Analyses of Opiates and Opioids in Whole Blood Using Tip-on-Tip wit...
Sensitive Analyses of Opiates and Opioids in Whole Blood Using Tip-on-Tip wit...DPX Technologies
 
methods_of_enzyme_assay_4.pdf
methods_of_enzyme_assay_4.pdfmethods_of_enzyme_assay_4.pdf
methods_of_enzyme_assay_4.pdfsaraso888
 

Similar to Enzyme Kinetics-2013 (20)

Siavosh Naji-Talakar[email protected]TITLE Enzyme Kineti.docx
Siavosh Naji-Talakar[email protected]TITLE Enzyme Kineti.docxSiavosh Naji-Talakar[email protected]TITLE Enzyme Kineti.docx
Siavosh Naji-Talakar[email protected]TITLE Enzyme Kineti.docx
 
project work
project workproject work
project work
 
MartucciNicole
MartucciNicoleMartucciNicole
MartucciNicole
 
Toxic Interaction Mechanism of food Colorant Sunset Yellow with trypsin by Sp...
Toxic Interaction Mechanism of food Colorant Sunset Yellow with trypsin by Sp...Toxic Interaction Mechanism of food Colorant Sunset Yellow with trypsin by Sp...
Toxic Interaction Mechanism of food Colorant Sunset Yellow with trypsin by Sp...
 
paper1-published
paper1-publishedpaper1-published
paper1-published
 
76 Lab Review
76 Lab Review76 Lab Review
76 Lab Review
 
Lab review
Lab reviewLab review
Lab review
 
Lab review
Lab reviewLab review
Lab review
 
A Simple and Validated RP-HPLC Method for the Estimation of Methylcobalamin i...
A Simple and Validated RP-HPLC Method for the Estimation of Methylcobalamin i...A Simple and Validated RP-HPLC Method for the Estimation of Methylcobalamin i...
A Simple and Validated RP-HPLC Method for the Estimation of Methylcobalamin i...
 
poster template 2015 4501
poster template 2015 4501poster template 2015 4501
poster template 2015 4501
 
Microchimica Acta Volume 75 issue 3-4 1981 [doi 10.1007_bf01196393] G. A. Mil...
Microchimica Acta Volume 75 issue 3-4 1981 [doi 10.1007_bf01196393] G. A. Mil...Microchimica Acta Volume 75 issue 3-4 1981 [doi 10.1007_bf01196393] G. A. Mil...
Microchimica Acta Volume 75 issue 3-4 1981 [doi 10.1007_bf01196393] G. A. Mil...
 
105_pdf
105_pdf105_pdf
105_pdf
 
Determination of metronidazole from the solid dosage form
Determination of metronidazole from the solid dosage formDetermination of metronidazole from the solid dosage form
Determination of metronidazole from the solid dosage form
 
JET JAR TEST
JET JAR TESTJET JAR TEST
JET JAR TEST
 
BCE-lab report
BCE-lab reportBCE-lab report
BCE-lab report
 
Blood amps poster_090210
Blood amps poster_090210Blood amps poster_090210
Blood amps poster_090210
 
FORMULATION AND EVALUATION OF ATORVASTATIN CALCIUM NIOSOMES.pptx
FORMULATION AND EVALUATION OF ATORVASTATIN CALCIUM NIOSOMES.pptxFORMULATION AND EVALUATION OF ATORVASTATIN CALCIUM NIOSOMES.pptx
FORMULATION AND EVALUATION OF ATORVASTATIN CALCIUM NIOSOMES.pptx
 
Sensitive Analyses of Opiates and Opioids in Whole Blood Using Tip-on-Tip wit...
Sensitive Analyses of Opiates and Opioids in Whole Blood Using Tip-on-Tip wit...Sensitive Analyses of Opiates and Opioids in Whole Blood Using Tip-on-Tip wit...
Sensitive Analyses of Opiates and Opioids in Whole Blood Using Tip-on-Tip wit...
 
methods_of_enzyme_assay_4.pdf
methods_of_enzyme_assay_4.pdfmethods_of_enzyme_assay_4.pdf
methods_of_enzyme_assay_4.pdf
 
kineticspectrophotometry.pdf
kineticspectrophotometry.pdfkineticspectrophotometry.pdf
kineticspectrophotometry.pdf
 

Enzyme Kinetics-2013

  • 1. 1 Tyrosinase Enzyme Kinetics Attached to L-Dopa and Inhibition Using Sodium Benzoate Alison O’Malley Metropolitan State University of Denver December 12, 2013 CHE: 4450 Lab Partners: Nellie Kaufman and Brett White
  • 2. 2 Abstract Tyrosinase enzymatic activity was studied from the mushroom Agaricus bisporous to find the kinetic constants Km and Vmax using L-dopa as the substrate. The inhibitor sodium benzoate at concentrations 0.1 mM and 0.2 mM was used to study the effects of inhibition on Tyrosinase. The values of the Km and Vmax reflected mixed inhibition as the numerical values both changed upon the addition of sodium benzoate. With the kinetic constant values and the Line-Weaver Burke graph, it was determined that sodium benzoate was a mixed inhibitor with an emphasis on uncompetitive inhibition. Experimental conditions such as human errors in pipetting, moisture in the air, cleanliness of equipment, and age of tyrosinase preparation influenced the data. Introduction Enzymes are biological macromolecule catalysts that play a very crucial part in the body, speeding up chemical reactions that would otherwise take a very long time to occur. They are characterized by two fundamental properties. First they increase the rate of chemical reactions without themselves being consumed or permanently altered by the reaction. Second, they increase reaction rates without altering the chemical equilibrium between reactants and products (4). Enzymes accomplish this by altering the substrates binding site to resemble the transition state. They bind to a substrate through two most common configurations. The primary configuration is through induced fit in which the confirmation of the enzyme and substrate are altered so it resembles the transition state. The second way is through the lock and key mechanism in which the
  • 3. 3 substrate fits perfectly into the active site of the enzyme. In cases where multiple enzymes are involved in the catalysis, specific amino acid side chains in the active site may react with the substrate and form bonds with reaction intermediates (1). Tyrosinase is a multifunctional, glycosylated, and copper-containing oxidase, which catalyzes the first two steps in mammalian melanogenesis (3). Inhibitors are molecules that bind to enzymes and decrease their activity. Two types of inhibitors exist with different results. One type is the inhibitors that are irreversible which initiate permanent damage to the enzyme. The other types are reversible and encompass four major categories: competitive, uncompetitive, non-competitive, and mixed competitive inhibition (5). The first purpose of this study was to determine the kinetic constants Km and Vmax using L-dopa as the substrate. The second portion was to examine the effects of a chosen inhibitor, sodium benzoate on the enzymatic activity of Tyrosinase and to determine the type of inhibition interaction of substrate and enzyme. Materials and Methods Enzyme kinetics of tyrosinase: The first step to this was to determine the optimal enzyme concentration of tyrosinase. This was done by varying the tyrosinase solution (preparation “A” ~100 units/ml), while keeping the 5 mM L-Dopa concentration constant. The total amount of material was always the same with the addition of 0.1 potassium phosphate buffer (pH 7.0) to bring the solution to 1.10 ml. The tyrosinase was stored on ice during the entire experiment. The spectrophotometer (Vernier™ probes) was set to 470 nm. The phosphate buffer was used to calibrate the spectrophotometer. The
  • 4. 4 phosphate buffer and L-dopa were pipetted directly into tubes according to the table 1. The tubes were then vortexed. The following steps were rapidly performed: 10 ml of enzyme solution from the first tube was poured into the first test tube, then poured into the 1-cm cuvette, and the cuvette was put into the spectrophotometer. Timing was immediately started and absorbance vs. time data was recorded every 2 minutes. Initial rate was determined from the graph on the computer. The second part of this experiment was to determine the Km and Vmax for L-dopa. In this part the enzyme concentration was held constant whilst the amount of L-dopa was varied from unsaturated-saturated. A table was set up similar to table 1. which also included 6 assays with 75 ul enzyme concentration and varying amounts of L-dopa from 0.15 to 5.0 mM, those amounts were 25, 50, 75, 100, 25 , and 1000 µl L-dopa. The remaining volume was phosphate buffer to make a final volume of 1.10 ml. The buffer and L-dopa was pipetted into a test tube and vortexed. This was repeated on all 6 test tubes and 6 enzyme assays were collected successively. The absorbances were collected at 2 min and the ΔA/min for each level of L-dopa was charted. Inhibition of tyrosinase: The previous experiment was performed twice with a 5 .0 mM sodium benzoate inhibitor added to each assay. The sodium benzoate was used in two different concentrations for each trial, 0.1 M and 0.2 M. The inhibitor amount was always the same during each trial. The optimal amount of enzyme determined in the previous was determined by varying the 5.0 mM L-Dopa amount. The other variable were held constant. The total amount of solution was also 1.10 ml with the addition of the potassium phosphate buffer solution. Six different amounts of L-Dopa were prepared as in table 3 & 4. This part of the experiment was performed the same way as
  • 5. 5 previously done. For each assay, the absorbance vs. time was recorded every 2 minutes. The data was converted to a Hanes-Wolf plot for each assay. The kinetic constants were determined from this plot. The data was then used to create a double reciprocal Lineweaver-Burk plot. The inhibition type of sodium benzoate was determined from this plot. Results Table 1: General Protocol for Tyrosinase Assay Material (µl) 1 2 3 4 5 Phosphate Buffer 90 80 50 25 0 L-Dopa 1000 1000 1000 1000 0 Tyrosinase 10 20 50 75 100 Table 2: Protocol for Tyrosinase Assay with enzyme concentration held constant and amount of L-Dopa varied over a range from non-saturation to saturation Material (µl) 1 2 3 4 5 6 Buffer 1000 975 950 925 775 250 L-Dopa 25 50 75 100 250 1000 Tyrosinase 75 75 75 75 75 75 Substrate conc. [S] (µM) 114 227 341 455 1140 4550 Table 3: 0.1 M Sodium Benzoate in a 5 mM solution in 0.1 M phosphate buffer pH 7.0 Material (µl) 1 2 3 4 5 6 Buffer 980 950 930 905 755 5 L-Dopa 25 50 75 100 250 1000 Tyrosinase 75 75 75 75 75 75 Inhibitor 22 22 22 22 22 22
  • 6. 6 Table 4: 0.2M Sodium Benzoate in a 5 mM solution in 0.1 M phosphate buffer pH 7.0 Material (µl) 1 2 3 4 5 6 Buffer 956 931 906 881 731 0 L-Dopa 25 50 75 100 250 1000 Tyrosinase 75 75 75 75 75 75 Inhibitor 44 44 44 44 44 44 Table 5: Kinetic constant values for Tyrosinase uninhibited and inhibited Kinetic Constant Tyrosinase Uninhibited 0.1mM sodium benzoate 0.2 mM sodium benzoate Km (µM) 490.35 293.25 259 Vmax (µM)/s 500 250 250 Figure 1: Spectral data of tyrosinase assay that was used to determine the optimal enzyme concentration R² = 0.9996 R² = 0.99946 0 0.05 0.1 0.15 0.2 0.25 0.3 0.35 0.4 0.45 0.5 0 20 40 60 80 100 120 Absorbance Time (s) Spectral Data of Tyrosinase Assay Assay 1 Assay 2 Assay 3 Assay 4 Assay 5 Linear (Assay 3) Linear (Assay 4)
  • 7. 7 Figure 2: Spectral data, which was used to determine the Km and Vmax of uninhibited tyrosinase assays y = 2E+06x + 980.7 R² = 0.99041 0 1000 2000 3000 4000 5000 6000 7000 8000 9000 10000 0 0.0005 0.001 0.0015 0.002 0.0025 0.003 0.0035 0.004 0.0045 0.005 [S]/v (sec) [S] (M) Hanes-Woolf Plot y = 4E+06x + 1037 R² = 0.99469 0 2000 4000 6000 8000 10000 12000 14000 16000 18000 20000 0 0.0005 0.001 0.0015 0.002 0.0025 0.003 0.0035 0.004 0.0045 0.005 [S}/v (sec) [S] (M) Hanes-Woolf Plot
  • 8. 8 Figure 3: Spectral data, which was used to determine the Km and Vmax of inhibited Tyrosinase assays with 0.1 mM sodium benzoate inhibitor Figure 4: Spectral data, which was used to determine the Km and Vmax of inhibited tyrosinase assays with 0.2 mM sodium benzoate inhibitor y = 4E+06x + 1037 R² = 0.99469 0 2000 4000 6000 8000 10000 12000 14000 16000 18000 20000 0 0.0005 0.001 0.0015 0.002 0.0025 0.003 0.0035 0.004 0.0045 0.005 [S}/v (sec) [S] (M) Hanes-Woolf Plot
  • 9. 9 Figure 5: Double reciprocal plot of uninhibited Tyrosinase and inhibited Tyrosinase by sodium benzoate The optimal enzyme concentration was determined to be 6.8 units/ml of Tyrosinase based off fig. 1. From this figure the optimal amount of enzyme was determined to be that used in assay 4 (table 1): 75 µl of ~100 units/ml were added to each ~1.10 ml assay. Table 2-4 show the amounts of each substance used for uninhibited tyrosinase and the two trials of inhibited tyrosinase by sodium benzoate. By using the data showed in fig. 2 the kinetic constants Km and Vmax for uninhibited tyrosinase were determined to be 490.35 µM and 500 µM/s. Figs.3 & 4 depicts the two reactions with the different concentrations of inhibitor. The significance of fig.5 is that it -6000000 -4000000 -2000000 0 2000000 4000000 6000000 8000000 10000000 12000000 14000000 -10000 -8000 -6000 -4000 -2000 0 2000 4000 6000 8000 10000 1/[v] (2/M) 1/[S](/M) Lineweaver-Burke Plot 0.1mM uninhibited 0.2mM Linear (uninhibited) Linear (0.2mM)
  • 10. 10 illustrates the type of inhibitor sodium benzoate. Table 5 shows the determined kinetic constants from each of three trials. Discussion In the first part of the experiment the optimal concentration of tyrosianse was determined using uninhibited tyrsoinase assay of varying concentrations while keeping L-Dopa constant. The data from spectrophotometer fig. 1 reveals that both assays 3 and 4 from table 2 delivered the most useful concentrations because the slopes were steep and very linear. Of the two, assay 4 was chosen because it had a larger concentration and subsequently gave a stronger spectrophotometer signal than assay 3. With the combination of the previous data and the L-Dopa concentrations from table 2 the kinetic constants for uninhibited tyrosinase were determined (Km= 400.35 µM; Vmax=500 µM/s). The literature values for uninhibited tyrosinase from the mushroom Agaricus bisporous were: Km= 170 µM-1500 µM (6)(7) and Vmax 24.5 ± 1.0 mM/min - 60 mM/min ≈ 1470(± 60) - 3600 mM/s (6)(7)(8). The Vmax as a result of this experiment did not fall within the literature range. However, the literature values varied greatly and therefore the values obtained in this experiment were likely valid results. Due to the fact these wide ranges exist it is evident that this experiment depends less on enzyme and substrate and more on experimental conditions. These experimental conditions include human error in pipetting, moisture in the lab as well as lab temperature, and age of the tyrosinase preparation
  • 11. 11 The data from the Lineweaver Burke plot fig.5 contradicts the numerical data of the kinetic constants table 5. At first the plot from fig.5 looks like it is reflecting mixed or non- competitive inhibition. However, upon evaluation of the numerical changes of the kinetic constants from table 5 (Vmax and Km change) in relation to the plot, the complete assessment indicated mixed inhibition. The plot from fig. 5 does not indicate classic uncompetitive inhibition, which would necessitate the uninhibited line and both the inhibited lines be parallel. However, only the line representing the 0.2 mM concentration of sodium benzoate and the uninhibited line demonstrate uncompetitive inhibition. In conclusion, the inhibition of tyrosinase by sodium benzoate is most likely mixed with a probable emphasis on uncompetitive. The experimental conditions strongly influenced the outcome of the Km and Vmax. This pertinent information could direct future experiments to produce more accurate results.
  • 12. 12 References 1) Sheng-Chang,T. (2009). An updated review of Tyrosinase inhibitors. International Journal of Molecular Science, 10(6), 2440-2475 DOI: http://dx.doi.org/10.3390%2Fijms10062440 2) Xie, J., Song, K.,Qiu, He,L., Q.,Huang,H., Chen, Q. (2007). Inhibitory effects of substrate analogues on enzyme activity and substrate specificities of mushroom tyrosinase. Food Chemistry, 103(4), 1075-1079 DOI:10.1016/j.foodchem.2006.04.030 3) Chung, K., Jeong, H., Jang, E., Choi, Y., Kim, D., Kim, S., Lee, K., Lee, H.,Chun, P., Byun, Y., Moon,H., Chung, H.(Oct2013). Characterization of a small molecular inhibitor of melanogenesis that inhibits tyrosinase activity and scavenges nitric oxide. BBA- General Studies. DOI: 1830(10), 4752-4761. 4) Cooper, G. (2000). The cell: A molecular approach. 2nd edition. Sinauer Associates. Retrieved on December 6, 2013, from http://www.ncbi.nlm.nih.gov/books/NBK9921/ 5) Cornish-Browden, A. (1974). A simple graphical method for determining the inhibition constants of mixed, uncompetitive, and non-competitive inhibitors. Biochem J, 137(1) 143-144. Rertreieved on December 9, 2013, from http://0- www.ncbi.nlm.nih.gov.skyline.ucdenver.edu/pmc/articles/PMC1166095/ 6) Sigma-Adlrich (2011). Tyrosinase from mushroom - lyophilized powder, ≥1000 unit/mg solid [Product Specification]. http://www.sigmaaldrich.com/Graphics/COfAInfo/SigmaSAPQM/SPEC/T3/T3824/T3824 BULK_SIGMA_.pdf
  • 13. 13 7) Selinheimo, E., Gasparetti, C., Mattinen, M., et al. (2009) Enzyme Microb. Technol. 44,1-10. 8) Espin, J. C., Varon, R., Fenoll, L. G., et al. (2000) Kinetic characterization of the substrate specificity and mechanism of mushroom tyrosinase. European J. Biochem., 267: 1270–1279.